| Pharmaceutical active ingredients: |
| EthoxazorutosidePapaverine HydrochlorideVitamin C (Ascorbic Acid) |
| Available forms, composition and doses of Solurutine Papaverine F. Retard: |
| N / A |
| Solurutine Papaverine F. Retard medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A03AD01 - PapaverineG04BE52 - Papaverine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Accenon | Ethotoin | Unidentified Pharmaceutical Company |
| Peganone | Ethotoin | Lundbeck; Abbott; Ovation Pharmaceuticals |
| Pegoanone | Ethotoin | Lundbeck |
| Ophtadil | Ethoxazorutoside; Nylidrin Hydrochloride; Vitamin C (Sodium Ascorbate); Vitamin E (D-Alpha Tocopherol Acetate) | Bausch and Lomb |
| Paveron SR | Ethoxazorutoside; Papaverine Hydrochloride; Vitamin C (Ascorbic Acid) | Karlspharma Pharmazeutische Produkte |
| Trisolvit | Ethoxazorutoside; Vitamin C (Sodium Ascorbate); Vitamin E (Tocophersolan) | Bausch and Lomb |
| Natura Perflex | Ethoxylated Propylene Glycol | Maurino Hnos. Laboratorio |
| Alterungsschutzmittel EC | Ethoxyquin | Unidentified Pharmaceutical Company |
| Antage AW | Ethoxyquin | Unidentified Pharmaceutical Company |
| Aries Antox | Ethoxyquin | Unidentified Pharmaceutical Company |